From genetics to biology: advancing mental health research in the Genomics ERA

[1]  John P. Rice,et al.  Identification of common genetic risk variants for autism spectrum disorder , 2019, Nature Genetics.

[2]  Annie W Shieh,et al.  Transcriptome-wide isoform-level dysregulation in ASD, schizophrenia, and bipolar disorder , 2018, Science.

[3]  Matthew W. Mosconi,et al.  Novel genes for autism implicate both excitatory and inhibitory cell lineages in risk , 2018, bioRxiv.

[4]  Alicia R. Martin,et al.  Discovery of the first genome-wide significant risk loci for attention deficit/hyperactivity disorder , 2018, Nature Genetics.

[5]  V. Anttila,et al.  Analysis of shared heritability in common disorders of the brain , 2018, Science.

[6]  P. Visscher,et al.  Common Disease Is More Complex Than Implied by the Core Gene Omnigenic Model , 2018, Cell.

[7]  D. Schaid,et al.  From genome-wide associations to candidate causal variants by statistical fine-mapping , 2018, Nature Reviews Genetics.

[8]  Chandra L. Theesfeld,et al.  Deep learning sequence-based ab initio prediction of variant effects on expression and disease risk , 2018, Nature Genetics.

[9]  Caroline F. Wright,et al.  Common genetic variants contribute to risk of rare severe neurodevelopmental disorders , 2018, Nature.

[10]  Ryan L. Collins,et al.  An analytical framework for whole-genome sequence association studies and its implications for autism spectrum disorder , 2018, Nature Genetics.

[11]  Jakob Grove,et al.  Common schizophrenia alleles are enriched in mutation-intolerant genes and in regions under strong background selection , 2018, Nature Genetics.

[12]  S. Hyman,et al.  The daunting polygenicity of mental illness: making a new map , 2018, Philosophical Transactions of the Royal Society B: Biological Sciences.

[13]  Warren W. Kretzschmar,et al.  Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression , 2017, Nature Genetics.

[14]  P. Visscher,et al.  10 Years of GWAS Discovery: Biology, Function, and Translation. , 2017, American journal of human genetics.

[15]  Gerome Breen,et al.  Genetic identification of brain cell types underlying schizophrenia , 2017, Nature Genetics.

[16]  Sharyn A. Lincoln,et al.  FORWARD: A Registry and Longitudinal Clinical Database to Study Fragile X Syndrome , 2017, Pediatrics.

[17]  T. Werge,et al.  Risk of Psychiatric Disorders Among Individuals With the 22q11.2 Deletion or Duplication: A Danish Nationwide, Register-Based Study , 2017, JAMA psychiatry.

[18]  Joan,et al.  Prevalence and architecture of de novo mutations in developmental disorders , 2017, Nature.

[19]  John P. A. Ioannidis,et al.  A manifesto for reproducible science , 2017, Nature Human Behaviour.

[20]  Stephan J Sanders,et al.  Polygenic transmission disequilibrium confirms that common and rare variation act additively to create risk for autism spectrum disorders , 2016, Nature Genetics.

[21]  Wei Cheng,et al.  Contribution of copy number variants to schizophrenia from a genome-wide study of 41,321 subjects , 2016, Nature Genetics.

[22]  Giulio Genovese,et al.  Increased burden of ultra-rare protein-altering variants among 4,877 individuals with schizophrenia , 2016, Nature Neuroscience.

[23]  A. Price,et al.  Dissecting the genetics of complex traits using summary association statistics , 2016, Nature Reviews Genetics.

[24]  Chandra L. Theesfeld,et al.  Genome-wide prediction and functional characterization of the genetic basis of autism spectrum disorder , 2016, Nature Neuroscience.

[25]  Stephan J Sanders,et al.  Refining the role of de novo protein truncating variants in neurodevelopmental disorders using population reference samples , 2016, Nature Genetics.

[26]  Minna Männikkö,et al.  Rare loss-of-function variants in SETD1A are associated with schizophrenia and developmental disorders , 2016, Nature Neuroscience.

[27]  Christopher S. Poultney,et al.  Insights into Autism Spectrum Disorder Genomic Architecture and Biology from 71 Risk Loci , 2015, Neuron.

[28]  Stephan J Sanders,et al.  A framework for the interpretation of de novo mutation in human disease , 2014, Nature Genetics.

[29]  D. G. MacArthur,et al.  Guidelines for investigating causality of sequence variants in human disease , 2014, Nature.

[30]  Adam J. Schwarz,et al.  CNVs conferring risk of autism or schizophrenia affect cognition in controls , 2013, Nature.

[31]  Daniel F. Gudbjartsson,et al.  A variant associated with nicotine dependence, lung cancer and peripheral arterial disease , 2008, Nature.